ロード中...
Effect of beraprost on pulmonary hypertension due to left ventricular systolic dysfunction
Beraprost is used to treat peripheral chronic arterial occlusive disease. However, the efficacy and safety of beraprost in patients with pulmonary hypertension (PH) due to left ventricular systolic dysfunction (PH-HFrEF) remains unknown. The primary objective of this study was to determine the effec...
保存先:
| 出版年: | Medicine (Baltimore) |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Wolters Kluwer Health
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6494404/ https://ncbi.nlm.nih.gov/pubmed/31008926 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000014965 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|